PARIS — During the meeting of the French Society of Ophthalmology, David Touboul, MD, talks about the use of intraoperative OCT for corneal transplantation procedures.
Uncategorized
“2015 World Medical Innovation Forum” Cites “Early Diagnosis and Treatment of Alzheimer’s Disease” as the Top Field Where Breakthroughs Will Be Made
ACTON, Mass.–(BUSINESS WIRE)–“2015 World Medical Innovation Forum” cites “Early Diagnosis and Treatment of Alzheimer’s Disease” as the top field where breakthroughs will be made
Dr Robert Lanza, Chief Scientific Officer of Ocata Therapeutics to be a Featured Speaker at The Common Good Forum
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that Robert Lanza, M.D., will be a featured speaker at The Common Good Forum “Venture Economics, Public Policy & Investment: Our Nation’s Future” on May 14, 2015, at the Waldorf Astoria in New York City. “Dr. Lanza’s pioneering research is providing hope for millions of people who may one day benefit from breakthrough c
Presbia Cooperatief U.A. to Participate in Jefferies Healthcare Conference
DUBLIN–(BUSINESS WIRE)–PRESBIA TO PARTICIPATE IN JEFFERIES HEALTHCARE CONFERENCE
BioTime, Inc. Reports First Quarter 2015 Results and Recent Corporate Accomplishments
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT:BTX) today reported financial results for the first quarter ended March 31, 2015 and provided a corporate update. “BioTime continues to advance its strategic product development programs. We are currently enrolling patients in a pivotal trial of Renevia™ for the treatment of HIV-associated lipoatrophy,” said Dr. Michael D. West, BioTime’s Chief Executive Officer. “At this year’s annual meeting of the American Association for Cancer Resea
Uncategorized
Intensive therapy reduces incidence, cost of ocular surgery in patients with type 1 diabetes
Intensive insulin therapy significantly reduced the long-term incidence and cost of ocular surgery in patients with type 1 diabetes, according to an analysis of data from the Diabetes Control and Complications Trial.The trial included 1,441 patients wi…